Home›People›Thilo Schroeder
TS

Thilo Schroeder

Managing Partner, Nextech and director at Stipple Bio. Also a director at Circle Pharma.

DirectorPublic companyRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Apr 6, 2026·Suggest an edit

About Thilo Schroeder

Thilo Schroeder is a managing partner, nextech and director at Stipple Bio.

Form D filings also name Thilo Schroeder as a director at Circle Pharma.

Thilo Schroeder reports to the SEC as a director or major shareholder of 4 public companies, including Revolution Medicines (RVMD), PMV Pharmaceuticals (PMVP) and ARS Pharmaceuticals (SPRY).

Thilo Schroeder first appears on SEC filings in 2019.

Experience

This experience comes from Thilo Schroeder's profile and from SEC filings. For roles taken from filings, the years are when the filings name Thilo Schroeder in the role, so the role may have started earlier or lasted longer.

Stipple Bio, Inc. Current
Managing Partner, Nextech and director
2026 – Present · Cambridge, MA
Develops targeted cancer medicines for people with cancer.
Induxion Therapeutics Current
Board Member
2026 – Present
Synnovation Therapeutics Current
Member Board of Directors
2023 – Present
Exo Therapeutics Current
Board Member
2021 – Present
Atavistik Bio Current
Member Board Of Directors
2021 – Present
Circle Pharma, Inc. Current
Director
2020 – Present · South San Francisco, CA
MOMA Therapeutics Current
Board Member
2020 – Present
Revolution Medicines, Inc. Current
Member Board Of Directors
2018 – Present · Public company (RVMD)
Nextech Invest Ltd. Current
Managing Partner
2012 – Present
IDRx
Board Observer
2022 – 2025
Mariana Oncology
Board Observer
2023 – 2024
Alterome Therapeutics, Inc
Member Board Of Directors
2022 – 2024
CARGO Therapeutics
Board Observer
2023
PMV Pharmaceuticals, Inc.
Director and 10% owner
Member Board Of Directors (2019 – 2023)
2019 – 2023 · Public company (PMVP)
Silverback Therapeutics
Board Member
2020 – 2022
ARS Pharmaceuticals, Inc.
Director
2020 · Public company (SPRY)
IDEAYA Biosciences, Inc.
Member Board Of Directors
2018 – 2020 · Public company (IDYA)
Black Diamond Therapeutics
Board Observer
2018 – 2020
ImaginAb
Member of the Board of Directors
2016 – 2020
Peloton Therapeutics
Member of the Board of Directors
2014 – 2019
Blueprint Medicines
Member of the Board of Directors
2014 – 2015

Key Colleagues at Startups

The people Thilo Schroeder works with at each company, as listed on that company's latest Form D.

Stipple Bio, Inc. · Form D, Apr 6, 2026
GV
Greg Verdine
Independent Director
OH
Owen Hughes
Independent Director
AR
Aaron Ring
Associate Professor, Fred Hutch and director
DD
Derek DiRocco
Partner, RA Capital Management and director
Jeffrey Landau
Jeffrey Landau
Chief Executive Officer and director
Circle Pharma, Inc. · Form D/A, Jan 10, 2025
SK
DE
David Earp
Executive officer and director
WM
Walter Moos
Director
PP
Paul Park
Executive officer
JJ
John Josey
Director

Sources

  1. SECStipple Bio, Inc. Form D, filed Apr 6, 2026
  2. SECCircle Pharma, Inc. Form D/A, filed Jan 10, 2025
  3. SECForms 3, 4 and 5 filed by Thilo Schroeder (SEC filer 1776412)